 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other Dec 18 Calls Today's Calls |
| Call Details | |||
| Auxilium Pharmaceuticals, Inc. and Pfizer Enter Agreement to Develop and Commercialize XIAFLEX(TM) in Europe Thu, Dec 18, 2008, 8:00 am Eastern
| |||
| About Auxilium Pharmaceuticals, Inc. (NasdaqGM:AUXL) | |||
| Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and select primary care physicians primarily in the United States. It markets Testim, a topical 1% testosterone gel, for the treatment of hypogonadism. The company’s product pipeline includes XIAFLEX, an injectable collagenase enzyme, which is in Phase III of development for the treatment of Dupuytren’s contracture; and in Phase II of development for the treatment of Peyronie’s Disease and Frozen Shoulder Syndrome. Its product pipeline also comprises AA4010, which is in Phase I of development for the treatment of overactive bladder using its transmucosal film delivery system. In addition, the company is developing one pain product, which is in preclinical stage using its transmucosal film delivery system. Further, it has rights to seven additional pain products, and products for hormone replacement and urologic disease using its transmucosal film delivery system, and options to indications using AA4500 for non-topical formulations. The company was founded in 1999 and is headquartered in Malvern, Pennsylvania. | |||
More Info: | |||
| About Pfizer (NYSE:PFE) | |||
| Pfizer, Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; Aricept for Alzheimer’s disease; and Zoloft for various disorders. It also offers Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; Genotropin for growth disorders; and Zyrtec/Zyrtec for allergies and hives. The company’s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections. Pfizer, Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York. | |||
More Info: | |||
